Target intelligence / Profile preview

Long-term potentiation (LTP)

Target
LTP
Molecular classification
Other
01

Overview

Long-term potentiation (LTP) is a persistent strengthening of synapses based on recent patterns of activity, widely regarded as a key cellular mechanism underlying learning and memory [StatPearls]. It is characterized by a long-lasting increase in the efficiency of synaptic transmission following high-frequency stimulation of a presynaptic neuron, primarily occurring in the hippocampus and other cortical regions [Wikipedia]. At the molecular level, LTP induction typically requires the activation of N-methyl-D-aspartate (NMDA) receptors, which leads to calcium influx and the subsequent activation of intracellular kinases like CaMKII that promote the insertion of AMPA receptors into the postsynaptic membrane [Nature Reviews Neuroscience]. Dysregulation of LTP is implicated in various neurological and psychiatric conditions, including Alzheimer’s disease, where synaptic loss and impaired plasticity drive cognitive decline [PubMed: 15217329]. While LTP is a physiological process rather than a single molecular target, therapeutic strategies often focus on modulating the glutamatergic system or neurotrophic factors to restore or enhance LTP in diseased states [NCBI]. However, pharmacological modulation of these pathways must be carefully managed, as excessive synaptic potentiation can lead to neurotoxicity or the development of epilepsy [StatPearls].

Other names
Synaptic plasticityActivity-dependent synaptic plasticityHebbian plasticitySynaptic potentiation
02

Mechanism of action

Enhancement of synaptic efficacy via the activation of N-methyl-D-aspartate (NMDA) receptors, calcium-dependent signaling cascades (e.g., CaMKII), and the trafficking of AMPA receptors to the postsynaptic membrane [StatPearls, PubMed: 15217329].

03

Biological functions

Learning and memorySynaptic plasticityNeural developmentSignal transduction
04

Disease associations

Alzheimer's diseaseSchizophreniaMajor depressive disorderPost-traumatic stress disorderNeurodegenerative disease
05

Safety considerations

ExcitotoxicitySeizure inductionCognitive disruptionPsychosisNeural over-activity
06

Interacting drugs

Memantine

5 more in the full profile.

07

Biomarkers

Field excitatory postsynaptic potential (fEPSP) slopeAMPA/NMDA receptor ratioBrain-derived neurotrophic factor (BDNF) levelsSynaptic density (PET imaging)

Beyond the preview

Go deeper on Long-term potentiation (LTP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long-term potentiation (LTP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call